“…The etiopathogenic and synergistic (vs. monotherapy) interventions on Antagonic‐Stress® in (brain) aging processes were demonstrated in (1) preclinical patterns, multiple corrections of hypoanabolism, hypercatabolism, oxidative stress, accompanied with lipofuscinolysis and brain aging pigment diminution; and also in (2) clinical psychogeriatrics, nootropic (anti‐impairment), psychotonic (antifatigue, energoactive), antidepressant, psychostabilizer, anxiolytic, adaptative (antistress) actions. 1‐4 The biological (orthomolecular) nature of its substances, synergism of multiple composition and actions, etiopathogenic, and polyinterventions in the aging process explain the multiple and positive results of Antagonic‐Stress® in brain senescence, and also the efficacy and superiority of this multivalent drug versus monotherapy for the aging phenomena.…”